King Pharmaceuticals Inc. / King Pharmaceuticals Research and Development Inc. / M.D. Industry / /
Event
Person Communication and Meetings / /
Facility
University of North Carolina / Chapel Hill Clinical Efficacy Results / Maryland Ballroom / /
IndustryTerm
noninvasive myocardial perfusion imaging / /
MedicalCondition
coronary artery disease / /
Organization
Drugs Advisory Committee / Division of Medical Imaging and Hematology Products / Division of Cardiology / Collaborative Studies Coordinating Center / University of North Carolina / U.S. Food and Drug Administration / Information Office / Center for Drug Evaluation and Research / Advisory Committee / Cardiovascular and Renal Drugs Advisory Committee / Division of Biometrics / /
Person
Jonathan C Fox / Acting Designated / Elaine Ferguson / James D. Neaton / Mark Levenson / Frank M. Bengel / Peter Conti / Silver Spring / Henry R. Black / Jonathan L. Halperin / Ellis Unger / James L. Tatum / Eric G Carter / Opening Remarks Rafel (Dwaine) / Robert A. Harrington / James E Udelson / Sanjay Kaul / A. Sebastian G. Schneeweiss / Mori J. Krantz / Robert Harrington / Libero Marzella / Neil J. Weissman / Darren K. McGuire / Emil P. Paganini / Michael Domanski / Lyle D. Bromeling / Rafel (Dwaine) Rieves / /
Position
Chief Science Officer / Director / Speaker / Chair / Chair F.A.C.C. Committee / Representative / Medical Team Leader / Professor of Biostatistics / Federal Official / /
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may